Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration

Am J Hypertens. 1999 Jan;12(1 Pt 1):73-5. doi: 10.1016/s0895-7061(98)00217-9.

Abstract

In 30 patients with essential hypertension and 30 healthy control subjects, we evaluated blood concentrations of B cell leukemia-2 (bcl-2), a protooncogene that can reduce apoptosis. Bcl-2 concentrations were higher in hypertensive than in normotensive subjects. The increase in pressure due to a cold pressor test caused a further increase in blood bcl-2 concentrations, in both hypertensive and normotensive subjects. Treatment of hypertensive patients with hypotensive drugs caused a reduction in bcl-2 concentrations, which was more marked after administration of lisinopril than of nifedipine. The results suggest that concentrations of bcl-2 are increased in patients with hypertension, which could be an important factor in cell proliferation underlying posthypertensive vascular remodeling. Moreover, lisinopril and nifedipine appear to be capable of reducing bcl-2 concentrations, with potentially beneficial effects on vascular modifications in patients with hypertension.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use*
  • Apoptosis / drug effects
  • Arteries / drug effects
  • Arteries / pathology
  • Biomarkers / blood
  • Blood Pressure / drug effects
  • Cell Division / drug effects
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension / blood*
  • Hypertension / drug therapy
  • Hypertension / pathology
  • Lisinopril / administration & dosage
  • Lisinopril / therapeutic use*
  • Lymphocyte Count / drug effects
  • Male
  • Middle Aged
  • Nifedipine / administration & dosage
  • Nifedipine / therapeutic use*
  • Proto-Oncogene Proteins c-bcl-2 / blood*
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Antihypertensive Agents
  • Biomarkers
  • Proto-Oncogene Proteins c-bcl-2
  • Vasodilator Agents
  • Lisinopril
  • Nifedipine